Vivek Jain

Dr. Vivek Jain is a Professor of Medicine and Infectious Diseases at the University of California, San Francisco (UCSF), affiliated with San Francisco General Hospital. He leads the Infectious Diseases Clinic, oversees SFGH’s Infection Control and Prevention Team, and directs outpatient therapies for HIV and COVID-19. His research focuses on HIV antiretroviral therapy (ART) in resource-limited settings, implementation science, and global health. He co-directs the SEARCH Study, a large-scale HIV testing and treatment initiative in East Africa, and has contributed to landmark trials like EARLI and RAPID-VL.

Education:

• B.A. Biochemistry, Harvard University (1998)
• M.D., Stanford University School of Medicine (2003)
• UCSF Residency/Chief Residency in Internal Medicine (2006–2007)
• Infectious Diseases Fellowship, UCSF (2009)
• M.A.S. in Clinical Research, UCSF (2010)

Research Interests:

Dr. Jain’s work bridges clinical practice and global health, emphasizing early ART initiation, HIV viral load monitoring, and pandemic response strategies. His studies address challenges in Sub-Saharan Africa, including streamlined care delivery and hypertension integration. He also investigates SARS-CoV-2 epidemiology and telemedicine applications for infectious diseases.

Publications:

His 150+ publications span HIV pathogenesis, implementation science, and pandemic preparedness. Key themes include CD4+ T-cell dynamics in HIV, population-level viral suppression, and racial disparities in vaccine uptake.

Awards:

• Fellow of the Infectious Diseases Society of America (FIDSA)

Grants & Teams:

Recipient of CDC and Gilead Sciences funding for studies like RAPID-VL (optimizing HIV viral load monitoring). Collaborates with institutions in Uganda/Kenya, including Makerere University and the Infectious Diseases Research Collaboration (IDRC).

Labs/Teams:

Leads the SEARCH Study and RAPID-VL Trial teams, focusing on scalable HIV interventions and pandemic response strategies in low-resource settings.